Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Basal Cell 3Pancreatic Neoplasms 2Urologic Neoplasms 1Urinary Bladder Neoplasms 1Telangiectasis 1Skin Neoplasms 1Rosacea 1Prostatic Neoplasms 1Precancerous Conditions 1Port-Wine Stain 1Pancreatic Intraductal Neoplasms 1Non-melanoma Skin Cancer 1Nevus, Pigmented 1Nasopharyngeal Neoplasms 1Mixed Tumor, Malignant 1Melanoma 1Lung Neoplasms 1Keratosis, Seborrheic 1Keratosis 1Hemangioma 1Glioma 1Carcinoma, Transitional Cell 1Carcinoma 1Barrett Esophagus 1

Interventions

Gemcitabine 9pembrolizumab 7Cisplatin 5enfortumab vedotin 4atezolizumab 4Trastuzumab 4Carboplatin 4Sunitinib 3Pemetrexed 3Mitomycin 3cabozantinib 2Water 2Sugammadex 2Standard of Care 2Saline Solution 2Paclitaxel 2Nivolumab 2Neostigmine 2Docetaxel 2Cetuximab 2Bevacizumab 2zidovudine 5'-monophosphate-mannose-albumin conjugate 1vinflunine 1valrubicin 1tucatinib 1tislelizumab 1testosterone 17 beta-cypionate 1temsirolimus 1relatlimab 1poly ICLC 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Urologic Neoplasms × Tomography, Optical Coherence × Clear all
NCT02108587 2016-10-20

Optical Coherence Tomography in Staging Patients With Upper Tract Urothelial Cancer

Case Comprehensive Cancer Center

Phase NA Withdrawn
Genitourinary

Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡